The Immediate Effect of Defocus Spectacles On the Choroid Thickness Using Optical Coherence Tomography on Children
Launched by VEJLE HOSPITAL · Jan 22, 2024
Trial Information
Current as of May 19, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Myopic children using Defocus Incorporated Multiple Segment Spectacle Lenses (DIMS) from the ongoing randomized clinical non-inferiority study: "Defocus Spectacle Lenses (DIMS) versus Orthokeratology lenses (OKL) for slowing myopia progression in children" (ClinicalTrials.gov Identifier NCT05134935)
- • Myopia at the time of inclusion in the NISDO study: -2.00 to -4.75 D spherical component and up to -2.50 D of regular astigmatism (both eyes)
- • Anisometropia \< 1,5 D cycloplegic spherical equivalent refractive error
- • Best corrected visual acuity (inclusive): 1.0 Snellen (equivalent to ≥ 3/5 letter on the 1.0 line = 83 ETDRS letters)
- Exclusion Criteria:
- • Manifest or intermittent squint
- • Contraindications to the use of OKL comprising (not exhaustive): keratoconus, chronic allergic conjunctivitis, and keratoconjunctivitis sicca
- • Previous eye surgery
- • Chronic eye disease demanding daily use of eye drops
- • Non-compliance to eye examinations (unstable fixation or anxiety towards contact lenses)
About Vejle Hospital
Vejle Hospital is a leading healthcare institution in Denmark, dedicated to advancing medical research and enhancing patient care through innovative clinical trials. With a focus on multidisciplinary collaboration, Vejle Hospital leverages its state-of-the-art facilities and experienced research teams to conduct rigorous studies across various therapeutic areas. Committed to ethical standards and patient safety, the hospital aims to contribute valuable insights to the medical community, ultimately improving treatment outcomes and healthcare practices. Through its clinical trial initiatives, Vejle Hospital strives to foster a culture of scientific excellence and drive advancements in health and medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vejle, Southern Denmark, Denmark
Patients applied
Trial Officials
Lou-Ann Andersen
Principal Investigator
Vejle Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported